HEADER LIGASE 21-AUG-24 9J8F TITLE STRUCTURAL INSIGHTS INTO BIRA FROM HAEMOPHILUS INFLUENZAE, A TITLE 2 BIFUNCTIONAL PROTEIN AS A BIOTIN PROTEIN LIGASE AND A TRANSCRIPTIONAL TITLE 3 REPRESSOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: BIFUNCTIONAL LIGASE/REPRESSOR BIRA; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HAEMOPHILUS INFLUENZAE RD KW20; SOURCE 3 ORGANISM_TAXID: 71421; SOURCE 4 GENE: BIRA; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI K-12; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 83333 KEYWDS BIRA, BIFUNCTIONAL PROTEIN, BIOTIN PROTEIN LIGASE, TRANSCRIPTIONAL KEYWDS 2 REPRESSOR, LIGASE EXPDTA X-RAY DIFFRACTION AUTHOR J.Y.LEE,K.H.JEONG,S.B.SON,J.H.KO REVDAT 1 11-SEP-24 9J8F 0 JRNL AUTH K.H.JEONG,S.B.SON,J.H.KO,M.LEE,J.Y.LEE JRNL TITL STRUCTURAL INSIGHTS INTO BIRA FROM HAEMOPHILUS INFLUENZAE, A JRNL TITL 2 BIFUNCTIONAL PROTEIN AS A BIOTIN PROTEIN LIGASE AND A JRNL TITL 3 TRANSCRIPTIONAL REPRESSOR. JRNL REF BIOCHEM.BIOPHYS.RES.COMMUN. V. 733 50601 2024 JRNL REFN ESSN 1090-2104 JRNL PMID 39213703 JRNL DOI 10.1016/J.BBRC.2024.150601 REMARK 2 REMARK 2 RESOLUTION. 2.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.19.1_4122: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.74 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 18089 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.249 REMARK 3 R VALUE (WORKING SET) : 0.245 REMARK 3 FREE R VALUE : 0.292 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.990 REMARK 3 FREE R VALUE TEST SET COUNT : 1807 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 28.7400 - 6.2100 0.99 1250 138 0.1925 0.2188 REMARK 3 2 6.2100 - 4.9400 0.99 1253 140 0.2248 0.2386 REMARK 3 3 4.9400 - 4.3200 0.99 1247 136 0.1895 0.2427 REMARK 3 4 4.3200 - 3.9200 1.00 1261 140 0.2095 0.2305 REMARK 3 5 3.9200 - 3.6400 1.00 1249 133 0.2393 0.2642 REMARK 3 6 3.6400 - 3.4300 1.00 1248 140 0.2536 0.3374 REMARK 3 7 3.4300 - 3.2600 1.00 1271 148 0.2559 0.2822 REMARK 3 8 3.2600 - 3.1200 1.00 1237 144 0.2940 0.3401 REMARK 3 9 3.1100 - 3.0000 1.00 1241 132 0.2901 0.3965 REMARK 3 10 3.0000 - 2.8900 1.00 1287 140 0.3133 0.4138 REMARK 3 11 2.8900 - 2.8000 1.00 1223 132 0.2994 0.3739 REMARK 3 12 2.8000 - 2.7200 1.00 1260 144 0.3192 0.4279 REMARK 3 13 2.7200 - 2.6500 0.99 1255 140 0.3421 0.3877 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.420 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 31.630 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.004 4616 REMARK 3 ANGLE : 0.749 6251 REMARK 3 CHIRALITY : 0.044 719 REMARK 3 PLANARITY : 0.005 800 REMARK 3 DIHEDRAL : 13.564 635 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 9J8F COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 21-AUG-24. REMARK 100 THE DEPOSITION ID IS D_1300050606. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-JUN-23 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PAL/PLS REMARK 200 BEAMLINE : 5C (4A) REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00003 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 9M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18223 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.650 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 7.700 REMARK 200 R MERGE (I) : 0.08400 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 22.3130 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.70 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.41200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 8.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: AF-P46363-F1 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.13 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.32 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M SODIUM ACETATE, 0.1 M MES, AND REMARK 280 20% (W/V) PEG 3350, PH 6.5, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 296K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+1/4 REMARK 290 4555 Y,-X,Z+3/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 100.14250 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 50.07125 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 150.21375 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG A 107 REMARK 465 GLY A 108 REMARK 465 ARG A 109 REMARK 465 ARG A 110 REMARK 465 GLY A 111 REMARK 465 ARG A 112 REMARK 465 GLN A 198 REMARK 465 THR A 199 REMARK 465 GLU A 200 REMARK 465 ILE A 201 REMARK 465 SER A 202 REMARK 465 GLN A 203 REMARK 465 GLY B 106 REMARK 465 ARG B 107 REMARK 465 GLN B 198 REMARK 465 THR B 199 REMARK 465 GLU B 200 REMARK 465 ILE B 201 REMARK 465 SER B 202 REMARK 465 GLN B 203 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 16 CG CD CE NZ REMARK 470 SER A 19 OG REMARK 470 GLU A 20 CG CD OE1 OE2 REMARK 470 GLU A 22 CG CD OE1 OE2 REMARK 470 LYS A 23 CG CD CE NZ REMARK 470 GLN A 34 CG CD OE1 NE2 REMARK 470 GLN A 87 CG CD OE1 NE2 REMARK 470 GLN A 113 CG CD OE1 NE2 REMARK 470 TRP A 114 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 114 CZ3 CH2 REMARK 470 LEU A 115 CG CD1 CD2 REMARK 470 ASP A 131 CG OD1 OD2 REMARK 470 LYS A 133 CG CD CE NZ REMARK 470 LYS A 179 CG CD CE NZ REMARK 470 ASN A 180 CG OD1 ND2 REMARK 470 LYS A 197 CG CD CE NZ REMARK 470 TYR A 205 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLN A 226 CG CD OE1 NE2 REMARK 470 GLU A 242 CG CD OE1 OE2 REMARK 470 GLU A 243 CG CD OE1 OE2 REMARK 470 GLU A 264 CG CD OE1 OE2 REMARK 470 GLU A 277 CG CD OE1 OE2 REMARK 470 SER B 19 OG REMARK 470 GLU B 22 CG CD OE1 OE2 REMARK 470 LYS B 23 CG CD CE NZ REMARK 470 ASN B 27 CG OD1 ND2 REMARK 470 GLU B 29 CG CD OE1 OE2 REMARK 470 GLU B 30 CG CD OE1 OE2 REMARK 470 LEU B 43 CG CD1 CD2 REMARK 470 ASP B 45 CG OD1 OD2 REMARK 470 GLN B 47 CG CD OE1 NE2 REMARK 470 ARG B 109 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 110 CG CD NE CZ NH1 NH2 REMARK 470 ARG B 112 CG CD NE CZ NH1 NH2 REMARK 470 TRP B 114 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP B 114 CZ3 CH2 REMARK 470 ASP B 131 CG OD1 OD2 REMARK 470 LYS B 133 CG CD CE NZ REMARK 470 LYS B 134 CG CD CE NZ REMARK 470 ILE B 175 CG1 CG2 CD1 REMARK 470 LYS B 197 CG CD CE NZ REMARK 470 ILE B 211 CG1 CG2 CD1 REMARK 470 GLN B 237 CG CD OE1 NE2 REMARK 470 GLU B 277 CG CD OE1 OE2 REMARK 470 LYS B 288 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LYS A 26 CD - CE - NZ ANGL. DEV. = -15.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TRP A 114 -61.50 -98.36 REMARK 500 ASN A 159 34.29 -148.43 REMARK 500 GLN A 237 -64.40 -105.53 REMARK 500 ARG B 110 -101.60 -123.34 REMARK 500 TRP B 114 -86.80 -105.09 REMARK 500 ASN B 159 34.32 -148.56 REMARK 500 GLN B 237 -63.60 -104.18 REMARK 500 REMARK 500 REMARK: NULL DBREF 9J8F A 1 302 UNP P46363 BIRA_HAEIN 1 302 DBREF 9J8F B 1 302 UNP P46363 BIRA_HAEIN 1 302 SEQRES 1 A 302 MET MET ASN PHE THR LEU LEU THR TYR LEU ALA ASP CYS SEQRES 2 A 302 GLN PRO LYS VAL ARG SER GLU LEU GLU LYS PHE SER LYS SEQRES 3 A 302 ASN LEU GLU GLU ASP ILE GLN GLN LEU ARG GLU ILE GLY SEQRES 4 A 302 LEU ASP ILE LEU VAL ASP GLY GLN ASP TYR ARG LEU VAL SEQRES 5 A 302 PRO MET LEU PRO LEU LEU ASN PRO GLN GLN ILE SER THR SEQRES 6 A 302 ALA LEU PHE PRO TYR SER ILE HIS TYR GLN PRO ILE ILE SEQRES 7 A 302 SER SER THR ASN GLU TRP ILE LEU GLN ASN ILE LEU SER SEQRES 8 A 302 LEU LYS LYS GLY ASP LEU CYS VAL ALA GLU TYR GLN THR SEQRES 9 A 302 ALA GLY ARG GLY ARG ARG GLY ARG GLN TRP LEU SER PRO SEQRES 10 A 302 PHE ALA GLY GLN ILE MET PHE SER PHE TYR TRP ALA PHE SEQRES 11 A 302 ASP PRO LYS LYS SER ILE GLU GLY LEU SER LEU VAL ILE SEQRES 12 A 302 GLY LEU ALA ILE ALA GLU VAL LEU ASN VAL GLN VAL LYS SEQRES 13 A 302 TRP PRO ASN ASP ILE LEU PHE ASP GLU ARG LYS LEU GLY SEQRES 14 A 302 GLY ILE LEU VAL GLU ILE ALA ASN HIS LYS ASN GLY MET SEQRES 15 A 302 LEU ASN LEU VAL ILE GLY ILE GLY ILE ASN VAL SER LEU SEQRES 16 A 302 SER LYS GLN THR GLU ILE SER GLN PRO TYR ALA GLU VAL SEQRES 17 A 302 CYS GLU ILE ASP PRO ASP VAL GLU ARG GLN THR LEU LEU SEQRES 18 A 302 PRO LYS LEU ILE GLN HIS LEU TYR THR ARG LEU ASN ILE SEQRES 19 A 302 PHE GLU GLN ASN GLY ILE ASP GLU GLU PHE GLN GLN ALA SEQRES 20 A 302 TRP GLN SER TYR ASN ALA PHE SER ASN SER GLU ILE ASN SEQRES 21 A 302 VAL LEU THR GLU GLN GLY VAL ILE SER GLY ILE GLU GLN SEQRES 22 A 302 GLY ILE ASP GLU ARG GLY TYR LEU LYS VAL LEU CYS GLY SEQRES 23 A 302 ASN LYS ILE GLN MET PHE ASN GLY GLY GLU VAL SER LEU SEQRES 24 A 302 ARG LYS LYS SEQRES 1 B 302 MET MET ASN PHE THR LEU LEU THR TYR LEU ALA ASP CYS SEQRES 2 B 302 GLN PRO LYS VAL ARG SER GLU LEU GLU LYS PHE SER LYS SEQRES 3 B 302 ASN LEU GLU GLU ASP ILE GLN GLN LEU ARG GLU ILE GLY SEQRES 4 B 302 LEU ASP ILE LEU VAL ASP GLY GLN ASP TYR ARG LEU VAL SEQRES 5 B 302 PRO MET LEU PRO LEU LEU ASN PRO GLN GLN ILE SER THR SEQRES 6 B 302 ALA LEU PHE PRO TYR SER ILE HIS TYR GLN PRO ILE ILE SEQRES 7 B 302 SER SER THR ASN GLU TRP ILE LEU GLN ASN ILE LEU SER SEQRES 8 B 302 LEU LYS LYS GLY ASP LEU CYS VAL ALA GLU TYR GLN THR SEQRES 9 B 302 ALA GLY ARG GLY ARG ARG GLY ARG GLN TRP LEU SER PRO SEQRES 10 B 302 PHE ALA GLY GLN ILE MET PHE SER PHE TYR TRP ALA PHE SEQRES 11 B 302 ASP PRO LYS LYS SER ILE GLU GLY LEU SER LEU VAL ILE SEQRES 12 B 302 GLY LEU ALA ILE ALA GLU VAL LEU ASN VAL GLN VAL LYS SEQRES 13 B 302 TRP PRO ASN ASP ILE LEU PHE ASP GLU ARG LYS LEU GLY SEQRES 14 B 302 GLY ILE LEU VAL GLU ILE ALA ASN HIS LYS ASN GLY MET SEQRES 15 B 302 LEU ASN LEU VAL ILE GLY ILE GLY ILE ASN VAL SER LEU SEQRES 16 B 302 SER LYS GLN THR GLU ILE SER GLN PRO TYR ALA GLU VAL SEQRES 17 B 302 CYS GLU ILE ASP PRO ASP VAL GLU ARG GLN THR LEU LEU SEQRES 18 B 302 PRO LYS LEU ILE GLN HIS LEU TYR THR ARG LEU ASN ILE SEQRES 19 B 302 PHE GLU GLN ASN GLY ILE ASP GLU GLU PHE GLN GLN ALA SEQRES 20 B 302 TRP GLN SER TYR ASN ALA PHE SER ASN SER GLU ILE ASN SEQRES 21 B 302 VAL LEU THR GLU GLN GLY VAL ILE SER GLY ILE GLU GLN SEQRES 22 B 302 GLY ILE ASP GLU ARG GLY TYR LEU LYS VAL LEU CYS GLY SEQRES 23 B 302 ASN LYS ILE GLN MET PHE ASN GLY GLY GLU VAL SER LEU SEQRES 24 B 302 ARG LYS LYS HET P33 A 401 22 HET 1PE B 401 16 HETNAM P33 3,6,9,12,15,18-HEXAOXAICOSANE-1,20-DIOL HETNAM 1PE PENTAETHYLENE GLYCOL HETSYN P33 HEPTAETHYLENE GLYCOL; PEG330 HETSYN 1PE PEG400 FORMUL 3 P33 C14 H30 O8 FORMUL 4 1PE C10 H22 O6 FORMUL 5 HOH *106(H2 O) HELIX 1 AA1 ASN A 3 ALA A 11 1 9 HELIX 2 AA2 VAL A 17 SER A 25 1 9 HELIX 3 AA3 ASN A 27 ILE A 38 1 12 HELIX 4 AA4 ASN A 59 LEU A 67 1 9 HELIX 5 AA5 SER A 80 ASN A 88 1 9 HELIX 6 AA6 ILE A 89 LEU A 92 5 4 HELIX 7 AA7 GLY A 138 ASN A 152 1 15 HELIX 8 AA8 GLU A 207 ASP A 212 1 6 HELIX 9 AA9 GLU A 216 ASN A 238 1 23 HELIX 10 AB1 ASP A 241 ASN A 252 1 12 HELIX 11 AB2 ASN B 3 ALA B 11 1 9 HELIX 12 AB3 ARG B 18 SER B 25 1 8 HELIX 13 AB4 ASN B 27 ILE B 38 1 12 HELIX 14 AB5 ASN B 59 LEU B 67 1 9 HELIX 15 AB6 SER B 80 ASN B 88 1 9 HELIX 16 AB7 ILE B 89 LEU B 92 5 4 HELIX 17 AB8 GLY B 138 ASN B 152 1 15 HELIX 18 AB9 GLU B 207 ASP B 212 1 6 HELIX 19 AC1 GLU B 216 GLY B 239 1 24 HELIX 20 AC2 ASP B 241 ASN B 252 1 12 SHEET 1 AA1 2 ILE A 42 ASP A 45 0 SHEET 2 AA1 2 ASP A 48 LEU A 51 -1 O ASP A 48 N ASP A 45 SHEET 1 AA2 7 ILE A 72 ILE A 78 0 SHEET 2 AA2 7 LEU A 97 GLN A 103 1 O VAL A 99 N HIS A 73 SHEET 3 AA2 7 GLN A 121 PHE A 130 -1 O SER A 125 N CYS A 98 SHEET 4 AA2 7 LEU A 183 ASN A 192 -1 O LEU A 185 N TRP A 128 SHEET 5 AA2 7 ARG A 166 ILE A 175 -1 N LEU A 172 O GLY A 188 SHEET 6 AA2 7 ASP A 160 PHE A 163 -1 N ILE A 161 O LEU A 168 SHEET 7 AA2 7 GLN A 154 LYS A 156 -1 N LYS A 156 O ASP A 160 SHEET 1 AA3 5 LYS A 288 PHE A 292 0 SHEET 2 AA3 5 LEU A 281 CYS A 285 -1 N VAL A 283 O GLN A 290 SHEET 3 AA3 5 GLY A 266 ILE A 275 -1 N GLN A 273 O LYS A 282 SHEET 4 AA3 5 GLU A 258 THR A 263 -1 N VAL A 261 O ILE A 268 SHEET 5 AA3 5 SER A 298 LYS A 301 -1 O ARG A 300 N ASN A 260 SHEET 1 AA4 3 LYS B 16 VAL B 17 0 SHEET 2 AA4 3 ASP B 48 LEU B 51 -1 O TYR B 49 N LYS B 16 SHEET 3 AA4 3 ILE B 42 ASP B 45 -1 N ASP B 45 O ASP B 48 SHEET 1 AA5 7 ILE B 72 ILE B 78 0 SHEET 2 AA5 7 LEU B 97 GLN B 103 1 O VAL B 99 N HIS B 73 SHEET 3 AA5 7 GLN B 121 PHE B 130 -1 O SER B 125 N CYS B 98 SHEET 4 AA5 7 LEU B 183 ASN B 192 -1 O LEU B 185 N TRP B 128 SHEET 5 AA5 7 ARG B 166 ALA B 176 -1 N LEU B 172 O GLY B 188 SHEET 6 AA5 7 ASP B 160 PHE B 163 -1 N ILE B 161 O LEU B 168 SHEET 7 AA5 7 GLN B 154 LYS B 156 -1 N LYS B 156 O ASP B 160 SHEET 1 AA6 5 LYS B 288 PHE B 292 0 SHEET 2 AA6 5 LEU B 281 CYS B 285 -1 N VAL B 283 O GLN B 290 SHEET 3 AA6 5 GLY B 266 ILE B 275 -1 N GLN B 273 O LYS B 282 SHEET 4 AA6 5 GLU B 258 THR B 263 -1 N THR B 263 O GLY B 266 SHEET 5 AA6 5 SER B 298 LYS B 301 -1 O SER B 298 N LEU B 262 CISPEP 1 PHE A 68 PRO A 69 0 7.59 CISPEP 2 TRP A 157 PRO A 158 0 1.50 CISPEP 3 PHE B 68 PRO B 69 0 7.06 CISPEP 4 TRP B 157 PRO B 158 0 1.00 CRYST1 56.472 56.472 200.285 90.00 90.00 90.00 P 41 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017708 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017708 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004993 0.00000